YETI Holdings
YETI
eBay
EBAY
Precision Drilling
PDS
Hutchmed (China)
HCM
Halozyme Therapeutics
HALO
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -1.58%2.56B | -1.14%2.61B | 4.89%2.62B | 18.47%10.48B | 17.82%2.75B | 12.77%2.6B | 26.62%2.64B | 17.32%2.49B | 7.44%8.84B | 10.19%2.34B |
Operating revenue | -1.58%2.56B | -1.14%2.61B | 4.89%2.62B | 18.47%10.48B | 17.82%2.75B | 12.77%2.6B | 26.62%2.64B | 17.32%2.49B | 7.44%8.84B | 10.19%2.34B |
Cost of revenue | -1.69%2.1B | -2.65%2.13B | 2.79%2.17B | 16.22%8.65B | 14.77%2.22B | 11.11%2.13B | 24.67%2.19B | 15.09%2.11B | 10.82%7.45B | 10.57%1.94B |
Gross profit | -1.29%459M | 6.26%475M | 16.89%443M | 30.52%1.82B | 33.42%531M | 21.41%465M | 37.12%447M | 31.60%379M | -7.61%1.4B | 8.15%398M |
Operating expense | 0.00%234M | -24.08%268M | -1.19%249M | 53.60%1.13B | 75.00%294M | 10.38%234M | 74.75%353M | 64.71%252M | -11.84%737M | -12.95%168M |
Selling and administrative expenses | 8.40%129M | 6.15%138M | 0.00%132M | 13.96%498M | 13.46%118M | 13.33%119M | 16.07%130M | 14.78%132M | 1.16%437M | -7.96%104M |
Research and development costs | -10.28%96M | -3.33%116M | -2.59%113M | 8.97%425M | 26.15%82M | 0.94%107M | 7.14%120M | 8.41%116M | -0.26%390M | -18.75%65M |
Depreciation amortization depletion | ---- | ---- | ---- | -33.33%2M | ---- | ---- | ---- | ---- | -70.00%3M | -50.00%1M |
-Depreciation and amortization | ---- | ---- | ---- | -33.33%2M | ---- | ---- | ---- | ---- | -70.00%3M | -50.00%1M |
Other operating expenses | 12.50%9M | -86.41%14M | 0.00%4M | 322.58%207M | 4,700.00%92M | 700.00%8M | 568.18%103M | 105.71%4M | -3,200.00%-93M | 0.00%-2M |
Operating profit | -2.60%225M | 120.21%207M | 52.76%194M | 4.70%690M | 3.04%237M | 35.09%231M | -24.19%94M | -5.93%127M | -2.37%659M | 31.43%230M |
Net non-operating interest income expense | -14.29%-24M | -31.58%-25M | -23.53%-21M | -48.15%-80M | -29.41%-22M | -61.54%-21M | -58.33%-19M | -41.67%-17M | 3.57%-54M | -30.77%-17M |
Non-operating interest income | 0.00%3M | -50.00%3M | 150.00%5M | 116.67%13M | 50.00%3M | 50.00%3M | 500.00%6M | 100.00%2M | 50.00%6M | 100.00%2M |
Non-operating interest expense | 12.50%27M | 12.00%28M | 36.84%26M | 55.00%93M | 31.58%25M | 60.00%24M | 92.31%25M | 46.15%19M | 0.00%60M | 35.71%19M |
Other net income (expense) | 50.00%-5M | -62.50%3M | 1M | 200.00%2M | 4M | -100.00%-10M | 33.33%8M | 50.00%-2M | 0 | |
Earnings from equity interest | 100.00%2M | 100.00%2M | 0.00%2M | 66.67%5M | --1M | 0.00%1M | 0.00%1M | 100.00%2M | 0.00%3M | --0 |
Other non- operating income (expenses) | 36.36%-7M | -85.71%1M | 50.00%-1M | 40.00%-3M | --3M | -83.33%-11M | 40.00%7M | 50.00%-2M | 28.57%-5M | --0 |
Income before tax | -1.99%197M | 120.48%183M | 59.63%174M | 1.49%612M | 2.34%219M | 31.37%201M | -29.06%83M | -8.40%109M | -1.79%603M | 35.44%214M |
Income tax | -13.43%58M | 46.67%44M | 38.24%47M | -30.90%123M | -114.04%-8M | 42.55%67M | -21.05%30M | -5.56%34M | 0.56%178M | 35.71%57M |
Net income | 3.73%139M | 162.26%139M | 71.62%127M | 15.06%489M | 44.59%227M | 26.42%134M | -32.91%53M | -10.84%74M | -2.75%425M | 36.52%157M |
Net income continuous Operations | 3.73%139M | 162.26%139M | 69.33%127M | 15.06%489M | 44.59%227M | 26.42%134M | -32.91%53M | -9.64%75M | -2.75%425M | 36.52%157M |
Minority interest income | 0 | 0 | 0 | -50.00%1M | 0 | 0.00%1M | 0 | 0 | 0.00%2M | 0.00%1M |
Net income attributable to the parent company | 2.99%138M | 160.38%138M | 70.27%126M | 15.37%488M | 45.51%227M | 27.62%134M | -32.91%53M | -10.84%74M | -2.76%423M | 35.65%156M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 2.99%138M | 160.38%138M | 70.27%126M | 15.37%488M | 45.51%227M | 27.62%134M | -32.91%53M | -10.84%74M | -2.76%423M | 35.65%156M |
Basic earnings per share | 10.76%1.75 | 180.33%1.71 | 77.91%1.53 | 18.11%5.74 | 50.56%2.71 | 30.58%1.58 | -32.97%0.61 | -9.47%0.86 | -2.21%4.86 | 36.80%1.8 |
Diluted earnings per share | 10.83%1.74 | 180.33%1.71 | 76.74%1.52 | 17.94%5.72 | 50.61%2.71 | 29.75%1.57 | -32.97%0.61 | -8.51%0.86 | -2.22%4.85 | 37.35%1.7993 |
Dividend per share | 3.03%0.68 | 3.03%0.68 | 3.03%0.68 | 3.10%2.66 | 3.03%0.68 | 3.13%0.66 | 3.13%0.66 | 3.13%0.66 | 37.23%2.58 | 3.13%0.66 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |